Angelor is an independent French venture capital firm and 'société à mission' based in Lyon, investing in early-stage French startups with a focus on health, agri-food, environment, and technology. It channels capital and operational mentorship from a network of business leaders and experts to support innovative entrepreneurs.
Deal activity increased 200% year-over-year (3 deals in the last 12 months). Their most common stage is series-a (47% of deals). Average disclosed round size is $25.9M (across 3 rounds with reported amounts).
Portfolio
14
Fund Size
—
Top Stage
Series A
Last 12 Mo
3
Team
HA
Henry Angleys
Investment Manager & Partner
SB
Sebastien Bonte
Président Fondateur
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
17 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Standing Ovation | Series B | $28.5M | Mar 2026 |
| Standing Ovation | Series A | $34.2M | Jan 2026 |
 Axoltis Pharma | Series A | — | Dec 2025 |
| AAXOLTIS | Series A | — | Dec 2025 |
| DDillico | Seed | — | Jul 2025 |
| Axoltis Pharma | Series A | — | Jan 2025 |
| AAXOLTIS | Series A | — | Jan 2025 |
| BBrenus Pharma | Series A | — | Jan 2024 |
| UURBASSIST | Unknown | — | Jan 2021 |
| CCLUB EMPLOYES | Seed | — | Mar 2020 |
 Mablink Bioscience | Series A | — | — |
| MMABLINK | Series A | — | — |
 Pixee Medical | Unknown | $15M | — |
 INALVE | Unknown | — | — |
| AAGRI LAB Leverage | Unknown | — | — |
| MMAG4Health | Unknown | — | — |
 Mexbrain | Seed | — | — |
Top Co-Investors
UI Investissement9 shared
Bpifrance6 shared
Noshaq3 shared
Newtree Impact2 shared
Seventure Partners2 shared
Bel Group2 shared
Astanor2 shared
Sofinnova Partners2 shared
Elaia2 shared
French Tech Seed Fund2 shared
BPI2 shared
Big Pi Ventures1 shared
Danone Manifesto Ventures1 shared
Good Startup1 shared
Innovacom1 shared
Last updated: 20 October 2026